[PSTX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[PSTX] Poseida Therapeutics, Inc.
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 31.71%
YoY- 38.34%
Quarter Report
PSTX's Result
PSTX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 28,142 24,995 9,352 20,013 10,343 9,921 116,306 -61.13%
PBT -24,274 -25,349 -31,671 -27,456 -38,847 -33,026 70,661 -
Tax 1,337 -6,040 -107 4,681 1,359 292 252 203.88%
NP -24,274 -23,990 -31,778 -27,456 -40,206 -33,318 70,409 -
Tax Rate - - - - - - -0.36% -
Total Cost 52,416 48,985 41,130 47,469 50,549 43,239 45,897 9.24%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -86.26 -95.98 -339.80 -137.19 -388.73 -335.85 60.54 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -0.25 -0.27 -0.35 -0.32 -0.47 -0.39 0.92 -
EPS Diluted -0.25 -0.27 -0.35 -0.32 -0.47 -0.39 0.92 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.